New Path Molecular Research

General Information

Company Name

Founded Year

2015

Location (Offices)

Founders / Decision Makers

Number of Employees

Industries

Biopharma, Biotechnology

Funding Stage

Social Media

New Path Molecular Research - Company Profile

New Path Molecular Research is a biopharma and biotechnology startup founded in 2015, with a vision that goes "Beyond ADCs." The company leverages cutting-edge chemistry techniques to develop novel, fully synthetic drug conjugates for pan-tumour biomarkers, aiming to overcome the limitations of conventional Antibody Drug Conjugates. Their initial focus is on pancreatic and colorectal cancer indications. Although specific details about their headquarters and last investment are not available at this time, New Path Molecular Research presents an intriguing venture in the biopharma sector, with potential for significant impact in cancer treatment.

Taxonomy: Drug Conjugates, Oncology, Synthetic Drug Conjugates, Pan-Tumour Biomarkers, Chemistry Techniques, Product Discovery, Molecular Research, Complex Functional Molecules, Peptides, Macrocycles, Flow Chemistry, Antibody Drug Conjugates, Pancreatic Cancer, Colorectal Cancer